SPADA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 184
EU - Europa 78
AS - Asia 24
Totale 286
Nazione #
US - Stati Uniti d'America 183
IT - Italia 26
IE - Irlanda 24
SE - Svezia 13
JO - Giordania 7
SG - Singapore 6
CN - Cina 5
HK - Hong Kong 5
RU - Federazione Russa 4
CH - Svizzera 3
ES - Italia 2
GB - Regno Unito 2
HR - Croazia 2
CA - Canada 1
DE - Germania 1
IN - India 1
UA - Ucraina 1
Totale 286
Città #
Fairfield 27
Chandler 24
Dublin 24
Lawrence 12
Woodbridge 12
Ashburn 10
Cambridge 10
Altamura 9
Houston 8
Wilmington 7
Boston 6
Princeton 6
Rome 6
Boardman 5
Seattle 5
Moscow 4
Singapore 4
Bern 3
Florence 3
Prad am Stilfser Joch 3
Barcelona 2
Buffalo 2
London 2
Milan 2
New York 2
San Diego 2
Shanghai 2
Zagreb 2
Ann Arbor 1
Arnsberg 1
Beijing 1
Hillsboro 1
Kent 1
Medford 1
Mountain View 1
Norwalk 1
Pune 1
Redmond 1
Toronto 1
Venezia 1
Totale 216
Nome #
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 69
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 64
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 51
Everolimus in pancreatic neuroendocrine carcinomas G3 45
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 36
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 33
Totale 298
Categoria #
all - tutte 1.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 0 0 0 21 0
2020/202148 7 0 7 11 0 0 0 6 2 7 8 0
2021/202241 0 0 7 2 3 5 0 2 4 0 4 14
2022/2023140 15 27 7 3 8 18 13 18 20 2 5 4
2023/202440 0 5 9 6 0 8 5 1 1 1 3 1
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 298